Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.74 |
| ▸ | CA4 | P22748 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ECE1 | P42892 | 3/20 | 0.45 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.45 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.45 |
| ▸ | ITGAL | P20701 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | OTC | P00480 | 1/20 | 0.41 |
| ▸ | ENO1 | P06733 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL5497426 | 0.94 | CA2 (0.71) | CA2CA4MEN1KMT2AECE1 | |
| Pala SCHEMBL59449 | 0.85 | CA2 (1.00) | CA2CA4MEN1KMT2ACA1 | |
| Sparfosic Acid SCHEMBL3514530 | 0.85 | CA2 (1.00) | CA2CA4MEN1KMT2ACA1 | |
| Pala SCHEMBL11121904 | 0.84 | CA2 (0.96) | CA2CA4MEN1KMT2ACA1 | |
| Pala SCHEMBL31389020 | 0.84 | CA2 (0.96) | CA2CA4MEN1KMT2ACA1 | |
| Sparfosic Acid SCHEMBL31237824 | 0.84 | CA2 (0.96) | CA2CA4MEN1KMT2ACA1 | |
| Pala SCHEMBL859680 | 0.84 | CA2 (0.96) | CA2CA4MEN1KMT2ACA1 | |
| SCHEMBL13997116 | 0.81 | CA2 (0.54) | CA2CA4MEN1KMT2AECE1 | |
| SCHEMBL14521397 | 0.81 | CA2 (0.54) | CA2CA4MEN1KMT2AECE1 | |
| SCHEMBL3510048 | 0.77 | ECE1 (0.50) | CA2CA4MEN1KMT2AECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | claimed |
| EP-2796112-B1 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2016-11-16 | — | — | EP | claimed |
| EP-0594667-B1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO NEURON INC (US) | 2001-09-19 | — | — | EP | claimed |
| EP-0554363-B1 | ALTERATION OF RATE AND CHARACTER OF HAIR GROWTH | HANDELMAN JOSEPH H (US) | 1998-06-24 | — | — | EP | claimed |
| US-5238955-A | Anticarcinogenic agents | ASTA PHARMA AG (DE) | 1993-08-24 | — | — | US | disclosed |
| EP-0324154-B1 | 1,2 BIS(AMINOMETHYL)CYCLOBUTANE-PLATINUM-COMPLEXES | ASTA Medica Aktiengesellschaft (DE) | 1993-03-17 | — | — | EP | disclosed |
| US-5194644-A | Antitumor agents; treatment of leukemia | ASTA PHARMA AG (DE) | 1993-03-16 | — | — | US | disclosed |
| US-5130308-A | Indole derivatives as anticarcinogenic agents | ASTA PHARMA (DE) | 1992-07-14 | — | — | US | disclosed |
| EP-0204989-B1 | USE OF PENICILLAMINE IN THE TREATMENT OF IMMUNE DEFICIENCY DISEASES | ASTA Medica Aktiengesellschaft (DE) | 1992-03-25 | — | — | EP | disclosed |
| EP-0451753-A1 | In the ethylenic moiety substituted phenylalkylethylenediamine-platinum (II or IV) derivatives and phenylalkyl-ethylenediamines | ASTA Medica Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| US-5023335-A | Antitumor agents | ASTA PHARMA AKTIENGESELLSCHAFT | 1991-06-11 | — | — | US | disclosed |
| US-4992553-A | Treatment of hormone dependent tumors | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1991-02-12 | — | — | US | disclosed |
| EP-0193055-B1 | ANTITUMORALS(1,2-DIPHENYL-ETHYLENE DIAMINE)-PLATINUM (II) COMPLEXES | ASTA Pharma AG (DE) | 1990-05-16 | — | — | EP | disclosed |
| EP-0324154-A2 | 1,2 Bis(aminomethyl)cyclobutane-platinum-complexes | ASTA Medica Aktiengesellschaft (DE) | 1989-07-19 | — | — | EP | disclosed |
| EP-0262498-A2 | Diamine platinum (II) complex compounds with a hydroxy-substituted 2-phenyl-indole ring | ASTA Pharma Aktiengesellschaft (DE) | 1988-04-06 | — | — | EP | disclosed |
| EP-0116955-B1 | COMPLEXES OF (1,2-DIPHENYL-ETHYLENE DIAMINE) PLATINUM (II) | Degussa Aktiengesellschaft (DE) | 1987-05-20 | — | — | EP | disclosed |
| EP-0204989-A2 | Use of penicillamine in the treatment of immune deficiency diseases | ASTA Medica Aktiengesellschaft (DE) | 1986-12-17 | — | — | EP | disclosed |
| EP-0193083-A1 | Anti-tumoral(1-arylmethyl-ethylene diamine)-platinum(II)-complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
| EP-0193055-A1 | Antitumorals(1,2-diphenyl-ethylene diamine)-platinum (II) complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
| EP-0116955-A2 | Complexes of (1,2-diphenyl-ethylene diamine) platinum (II) | Degussa Aktiengesellschaft (DE) | 1984-08-29 | — | — | EP | disclosed |